Ectodysplasin A2 receptor

Results: 1



#Item
1EDA / Hypodontia / Ectodysplasin A2 receptor / Genodermatoses / Hypohidrotic ectodermal dysplasia / Ectodermal dysplasia

  EDI200 – A Biotherapeutic For Treating X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) Phase 2 clinical study initiated Preclinical data strongly confirms validity of target pathway and therapeutic approach

Add to Reading List

Source URL: edimerpharma.com

Language: English - Date: 2014-06-05 15:51:36
UPDATE